Adlai Nortye (ANL) Leases (2023 - 2025)
Adlai Nortye (ANL) reported Leases of $636000.0 for Q2 2025, down 6.19% year-over-year from $678000.0 in Q2 2024, and down 33.89% on a QoQ basis from $962000.0 in Q4 2024.
Adlai Nortye (ANL) has 3 years of Leases data on file, last reported at $636000.0 in Q2 2025.
- Quarterly Leases fell 6.19% year-over-year to $636000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $636000.0 (down 6.19% YoY) and the FY2024 annual result came in at $962000.0, down 16.64% from the prior year.
- Leases retreated to $636000.0 in Q2 2025 per ANL's latest filing, from $962000.0 in the prior quarter.
- Across five years, Leases topped out at $1.2 million in Q4 2023 and bottomed at $636000.0 in Q2 2025.
- The 3-year median for Leases is $820000.0 (2024), against an average of $857500.0.
- The widest annual swing landed in 2024, when Leases fell 16.64%; it then fell 6.19% in 2025.
- Tracing ANL's Leases over 3 years: stood at $1.2 million in 2023, then declined by 16.64% to $962000.0 in 2024, then slumped by 33.89% to $636000.0 in 2025.
- Per Business Quant, the three latest ANL Leases figures stand at $636000.0 (Q2 2025), $962000.0 (Q4 2024), and $678000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 636,000.00 |
| Dec 31, 2024 | 962,000.00 |
| Jun 30, 2024 | 678,000.00 |
| Dec 31, 2023 | 1.15 Mn |